Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

40.79

-1.56 (-3.68%)

At close: Feb 27, 2026, 4:00 PM EST

41.11

+0.32 (0.78%)

After-hours: Feb 27, 2026, 7:22 PM EST

Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	714.59	92.65	45.68	43.46	79.67
Short-Term Investments	-	548.21	115.04	71.19	-
Cash & Short-Term Investments	714.59	640.85	160.72	114.65	79.67
Cash Growth	11.51%	298.75%	40.18%	43.90%	48.26%
Other Receivables	-	3.77	0.51	-	-
Receivables	-	3.77	0.51	-	-
Prepaid Expenses	14.29	5.68	8.56	10.33	2.38
Other Current Assets	-	0.91	2.24	0.72	0.48
Total Current Assets	728.88	651.22	172.02	125.7	82.54
Property, Plant & Equipment	1.92	4.33	3.04	5.22	-
Long-Term Investments	-	-	-	0.06	0.87
Other Long-Term Assets	3.93	0.13	0.48	0.46	0.34
Total Assets	734.73	655.68	175.55	131.44	83.75
Accounts Payable	21.9	7.67	11.12	11.99	1.39
Accrued Expenses	31.01	16.22	8.75	10.96	5.93
Current Portion of Leases	0.55	1.48	2.44	2.65	-
Other Current Liabilities	-	-	-	-	0.38
Total Current Liabilities	53.46	25.37	22.3	25.6	7.69
Long-Term Debt	74.84	50.69	49.88	24.81	4.92
Long-Term Leases	1.92	2.47	1.4	3.83	-
Other Long-Term Liabilities	-	-	0.29	0.29	1.54
Total Liabilities	130.21	78.53	73.86	54.53	14.16
Common Stock	0.07	0.06	0.04	0.03	0.02
Additional Paid-In Capital	1,365	1,038	410.49	290.22	193.63
Retained Earnings	-760.87	-461.25	-309.1	-213.11	-124.06
Comprehensive Income & Other	0.79	0.39	0.25	-0.22	-
Total Common Equity	604.52	577.16	101.69	76.91	69.59
Shareholders' Equity	604.52	577.16	101.69	76.91	69.59
Total Liabilities & Equity	734.73	655.68	175.55	131.44	83.75
Total Debt	77.31	54.64	53.71	31.29	4.92
Net Cash (Debt)	637.28	586.21	107.01	83.37	74.75
Net Cash Growth	8.71%	447.82%	28.36%	11.53%	39.10%
Net Cash Per Share	9.92	10.60	2.51	3.14	5.56
Filing Date Shares Outstanding	65.63	63.75	54.45	44.26	27.05
Total Common Shares Outstanding	65.63	63.56	44.45	27.8	21.28
Working Capital	675.43	625.85	149.72	100.1	74.85
Book Value Per Share	9.21	9.08	2.29	2.77	3.27
Tangible Book Value	604.52	577.16	101.69	76.91	69.59
Tangible Book Value Per Share	9.21	9.08	2.29	2.77	3.27

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q